title: Peramivir: another tool for influenza treatment?
authors.affiliation: Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. bwc8@cdc.gov
authors.forename: Seema
authors.initials: S
authors.lastname: Jain
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Fry
mesh_terms: D000146:Acids, Carbocyclic; D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003517:Cyclopentanes / Q000008:administration & dosage* / Q000009:adverse effects; D015507:Drugs, Investigational / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006146:Guanidines / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000188:drug therapy* / Q000401:mortality / Q000821:virology*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States; D055815:Young Adult
chemical_list: D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D015507:Drugs, Investigational; D006146:Guanidines; C414210:peramivir